HCN News Team – Page 8 – Highly Capitalized

Thursday, June 25, 2026 We Follow The Money.

About HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Cannabis and Alcohol Push Back Against Proposed Hemp Regulation Bill

HCN News Team2026-05-18T04:23:47-08:00May 18th, 2026|Hemp|

WASHINGTON – Competing industry interests are shaping the debate over ...

Research and Markets Report Sets a $28B Target on Cannabis Tech

HCN News Team2026-05-18T02:48:54-08:00May 18th, 2026|Insights, Report|

DUBLIN – The Cannabis industry has transformed from plant cultivation ...

Europe Medical Cannabis to Reach $13 Billion by 2034, IMARC Group Reports

HCN News Team2026-05-15T06:20:40-08:00May 15th, 2026|Insights|

NEW YORK – A fresh industry report highlights substantial potential ...

Bioxyne Double-Strikes in LATAM and Europe

HCN News Team2026-05-15T04:46:10-08:00May 15th, 2026|Business, International|

SYDNEY – Bioxyne Limited, an international health and life sciences ...

Rubicon Organics Reports Q1 2026 Financial Results

HCN News Team2026-05-15T03:08:20-08:00May 15th, 2026|Business, Report|

VANCOUVER – Rubicon Organics Inc. delivered its first-quarter report, revealing ...

BREAKING: Colorado Passes Landmark Ibogaine Research Bill, Expanding the State’s Natural Medicine Framework

HCN News Team2026-05-14T16:05:17-08:00May 14th, 2026|Business, Insights|

DENVER- Colorado has taken another major step in the evolution ...

The DEA Window: The Real Fight Is Over Who Qualifies as Medical Cannabis

HCN News Team2026-05-14T14:50:26-08:00May 14th, 2026|Business, Insights|

WASHINGTON, D.C. - The real significance of the DEA window ...

Study: Older Americans Are Turning to Cannabis as an Alternative to Pharmaceuticals

HCN News Team2026-05-14T14:31:06-08:00May 14th, 2026|Business, Insights|

NEW YORK - Older Americans are increasingly looking at Cannabis ...

Definium Doses First Patient in Second Phase 3 LSD-Based Trial

HCN News Team2026-05-14T05:20:29-08:00May 14th, 2026|Psychedelics|

NEW YORK – Definium Therapeutics Inc. has taken another step ...

Glass House Brands Reports Q1 2026 Financial Results

HCN News Team2026-05-14T03:47:27-08:00May 14th, 2026|Business, Report|

LONG BEACH – Glass House Brands Inc. released its first-quarter ...

Previous 789 Next

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.